Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 17
2003 26
2004 19
2005 20
2006 15
2007 27
2008 29
2009 15
2010 21
2011 22
2012 19
2013 15
2014 19
2015 20
2016 19
2017 9
2018 11
2019 11
2020 13
2021 31
2022 23
2023 33
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

372 results

Results by year

Filters applied: . Clear all
Page 1
Homologous and Heterologous Covid-19 Booster Vaccinations.
Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW Jr, Bäcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Posavad CM, Archer JI, Crandon S, Nayak SU, Szydlo D, Zemanek JA, Dominguez Islas CP, Brown ER, Suthar MS, McElrath MJ, McDermott AB, O'Connell SE, Montefiori DC, Eaton A, Neuzil KM, Stephens DS, Roberts PC, Beigel JH; DMID 21-0012 Study Group. Atmar RL, et al. N Engl J Med. 2022 Mar 17;386(11):1046-1057. doi: 10.1056/NEJMoa2116414. Epub 2022 Jan 26. N Engl J Med. 2022. PMID: 35081293 Free PMC article. Clinical Trial.
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.
Oslin DW, Lynch KG, Shih MC, Ingram EP, Wray LO, Chapman SR, Kranzler HR, Gelernter J, Pyne JM, Stone A, DuVall SL, Lehmann LS, Thase ME; PRIME Care Research Group; Aslam M, Batki SL, Bjork JM, Blow FC, Brenner LA, Chen P, Desai S, Dieperink EW, Fears SC, Fuller MA, Goodman CS, Graham DP, Haas GL, Hamner MB, Helstrom AW, Hurley RA, Icardi MS, Jurjus GJ, Kilbourne AM, Kreyenbuhl J, Lache DJ, Lieske SP, Lynch JA, Meyer LJ, Montalvo C, Muralidhar S, Ostacher MJ, Paschall GY, Pfeiffer PN, Prieto S, Przygodzki RM, Ranganathan M, Rodriguez-Suarez MM, Roggenkamp H, Schichman SA, Schneeweis JS, Simonetti JA, Steinhauer SR, Suppes T, Umbert MA, Vassy JL, Voora D, Wiechers IR, Wood AE. Oslin DW, et al. Among authors: lynch kg. JAMA. 2022 Jul 12;328(2):151-161. doi: 10.1001/jama.2022.9805. JAMA. 2022. PMID: 35819423 Free PMC article. Clinical Trial.
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment.
Egan H, Treacy O, Lynch K, Leonard NA, O'Malley G, Reidy E, O'Neill A, Corry SM, De Veirman K, Vanderkerken K, Egan LJ, Ritter T, Hogan AM, Redmond K, Peng L, Che J, Gatlin W, Jayaraman P, Sheehan M, Canney A, Hynes SO, Kerr EM, Dunne PD, O'Dwyer ME, Ryan AE. Egan H, et al. Among authors: lynch k. Cell Rep. 2023 May 30;42(5):112475. doi: 10.1016/j.celrep.2023.112475. Epub 2023 May 10. Cell Rep. 2023. PMID: 37167967 Free article.
Sphingosine 1-phosphate signaling in perivascular cells enhances inflammation and fibrosis in the kidney.
Tanaka S, Zheng S, Kharel Y, Fritzemeier RG, Huang T, Foster D, Poudel N, Goggins E, Yamaoka Y, Rudnicka KP, Lipsey JE, Radel HV, Ryuh SM, Inoue T, Yao J, Rosin DL, Schwab SR, Santos WL, Lynch KR, Okusa MD. Tanaka S, et al. Among authors: lynch kr. Sci Transl Med. 2022 Aug 17;14(658):eabj2681. doi: 10.1126/scitranslmed.abj2681. Epub 2022 Aug 17. Sci Transl Med. 2022. PMID: 35976996 Free PMC article.
Drugging sphingosine kinases.
Santos WL, Lynch KR. Santos WL, et al. Among authors: lynch kr. ACS Chem Biol. 2015 Jan 16;10(1):225-33. doi: 10.1021/cb5008426. Epub 2014 Nov 19. ACS Chem Biol. 2015. PMID: 25384187 Free PMC article. Review.
Imidazole-based sphingosine-1-phosphate transporter Spns2 inhibitors.
Shrader CW, Foster D, Kharel Y, Huang T, Lynch KR, Santos WL. Shrader CW, et al. Among authors: lynch kr. Bioorg Med Chem Lett. 2023 Nov 15;96:129516. doi: 10.1016/j.bmcl.2023.129516. Epub 2023 Oct 11. Bioorg Med Chem Lett. 2023. PMID: 37832799
Sphingosine 1-phosphate chemical biology.
Lynch KR, Macdonald TL. Lynch KR, et al. Biochim Biophys Acta. 2008 Sep;1781(9):508-12. doi: 10.1016/j.bbalip.2008.06.006. Epub 2008 Jun 25. Biochim Biophys Acta. 2008. PMID: 18638568 Free PMC article. Review.
Novel TRPM7 inhibitors with potent anti-inflammatory effects in vivo.
Busey GW, Manjegowda MC, Huang T, Iobst WH, Naphade SS, Kennedy JA, Doyle CA, Seegren PV, Lynch KR, Desai BN. Busey GW, et al. Among authors: lynch kr. bioRxiv [Preprint]. 2023 Aug 26:2023.05.22.541802. doi: 10.1101/2023.05.22.541802. bioRxiv. 2023. PMID: 37662207 Free PMC article. Preprint.
Lysophospholipid receptor nomenclature.
Lynch KR. Lynch KR. Biochim Biophys Acta. 2002 May 23;1582(1-3):70-1. doi: 10.1016/s1388-1981(02)00138-5. Biochim Biophys Acta. 2002. PMID: 12069811 Review. No abstract available.
372 results